Skip to content

Brief Interventions on Smoking for Hormonal Contraceptive Users

Brief Interventions on Smoking for Hormonal Contraceptive Users

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00726141
Acronym
BRISC
Enrollment
699
Registered
2008-07-31
Start date
2004-10-31
Completion date
2007-10-31
Last updated
2008-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Keywords

Brief Intervention, Smoking Cessation, Motivational Interviewing, Expert System, Readiness to Change, Hormonal Contraceptive, Adolescents

Brief summary

Despite rising smoker rates, particularly in girls and young women, only few studies have focused on smoking cessation in young smokers. Gynaecologist practices may be an ideal setting to proactively intervene with young female smokers. Elevated health risks of smoking while using hormonal contraceptives could be a successful approach to gain young women's attention on smoking cessation. The purpose of this study is to evaluate the effectiveness of a smoking cessation intervention for girls and young women visiting gynaecologist practices and using hormonal contraceptives.

Detailed description

In the randomized controlled trial, female smokers aged 14-25 will be recruited in practices of gynaecologists. Intervention within the practice consists of a 30 minutes counseling session based on Motivational Interviewing, a standardised physician letter focusing on the elevated health risks of smoking while using hormonal contraceptives and a stage-matched self-help manual. After four weeks, an expert system feedback letter will be sent. In the intervention group, no smoking intervention will be given. Follow-up assessments will be conducted after 12 months, including saliva cotinine measures.

Interventions

BEHAVIORALBrief intervention, Motivational Interviewing, Expert System

Motivational Interviewing, stage-tailored self-help manual, physician letter, expert system feedback letter

Sponsors

University of Luebeck
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Age 14-25 * Having smoked at least 1 cigarette within last 4 weeks * Use of hormonal contraceptives or intention for prescription within next 2 weeks

Exclusion criteria

* Pregnancy * Emergency treatment

Design outcomes

Primary

MeasureTime frame
Smoking cessation12 months

Secondary

MeasureTime frame
Reduction of smoking12 months
Readiness to change variables12 months
Level of nicotine dependence12 months
Quit attempts12 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026